GlassScriptPhysician profile
Timothy P Milner
NPI 1558572164
$2,576.56
in general payments reported to CMS, 2019-2025
26 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $199 · 2021: $240 · 2022: $349 · 2023: $172 · 2024: $582 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729 · Travel and Lodging: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.46 |
| Travel and Lodging | $178.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $673.32 | 2019-2022 | |
| Boston Scientific Corporation | $351.58 | 2019-2024 | Varithena Administration Pack |
| Terumo Medical Corporation | $298.70 | 2024 | Glidewire, Glidesheath Slender, Metacross Otw |
| Bard Peripheral Vascular, INC. | $215.59 | 2019-2024 | Venovo, Venclose Maven Catheter |
| Medtronic, INC. | $179.36 | 2024-2025 | Venaseal |
| Endologix LLC | $143.23 | 2019 | |
| Organogenesis INC. | $86.57 | 2022-2024 | Puraply |
| Angiodynamics, INC. | $83.43 | 2021 | |
| Janssen Pharmaceuticals, INC | $57.88 | 2019-2022 | |
| Cordis US Corp. | $54.60 | 2023-2025 | Mynx Control |
| Becton, Dickinson and Company | $46.17 | 2024 | Lutonix Drug Coated Balloon, Venclose Maven Catheter |
| Cook Medical LLC | $40.26 | 2019-2021 | |
| Tactile Systems Technology INC | $37.98 | 2022 | |
| Medtronic Vascular, INC. | $36.71 | 2019 | |
| Nevro Corp. | $36.39 | 2023 | Senza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $34.75 | 2023-2024 | |
| Abbott Laboratories | $33.65 | 2019-2020 | |
| Philips North America LLC | $33.59 | 2022 | |
| Medline Industries LP | $32.53 | 2019-2024 | |
| Venclose INC. | $18.10 | 2019 | |
| Allergan, INC. | $16.96 | 2019 | |
| Acera Surgical, INC. | $15.74 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.52 | 2022 | |
| Triad Life Sciences INC. | $14.91 | 2022 | |
| W. L. Gore & Associates, INC. | $11.41 | 2019 | |
| Kerecis Limited | $7.63 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Milner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.